Value proposition

Rare cells analysis with single cell precision.

Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization. The company’s CELLSEARCH® and DEPArrayTM technologies together provide an end-to-end solution for enumeration and sorting of rare cells with single-cell precision.

Menarini Silicon Biosystems, based in Bologna, Italy, and Huntingdon Valley, PA, US, is a wholly-owned subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology, and diagnostics company headquartered in Florence, Italy, with 17,640 employees in 136 countries.

Read our Netiquette here: www.siliconbiosystems.com/netiquette

cell sorting, circulating tumor cells, single cell analysis, resolving tumor heterogeneity, rare cell isolation, Forensics, CELLSEARCH, CTC, Liquid biopsy, circulating cell, cancer, lab services, biopharma, multiple myeloma, breast cancer, CTC enumeration, clinical trial, genomic profiling, lowpass sequencing, cancer panel, molecual analysis, deparray, and cell sorting